Clinical trial
Patient-derived Tumor-like Cell Clusters (PTC) in Personalizing Neoadjuvant Therapy for Patients With Advanced Gastrointestinal Tumor: A Prospective, Open-label and Randomized Study
NCT05280210 is registered in ClinicalTrials.gov with Peking University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient-derived Tumor-like Cell Clusters (PTC) in Personalizing Neoadjuvant Therapy for Patients With Advanced Gastrointestinal Tumor: A Prospective, Open-label and Randomized Study
- Lead sponsor
- Peking University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 1, 2022
- Completion date
- December 31, 2024
- Enrollment
- 420 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.